Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · Real-Time Price · USD
0.533
-0.001 (-0.17%)
Nov 4, 2024, 3:59 PM EST - Market closed
-0.17%
Market Cap 73.96M
Revenue (ttm) 110.94M
Net Income (ttm) -3.33M
Shares Out 138.71M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,874
Open 0.534
Previous Close 0.534
Day's Range 0.533 - 0.549
52-Week Range 0.510 - 1.450
Beta 0.38
Analysts Strong Buy
Price Target 3.00 (+462.64%)
Earnings Date Nov 11, 2024

About XTNT

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the oste... [Read more]

Industry Medical Devices
Sector Healthcare
CEO Sean Browne
Employees 215
Stock Exchange NYSEAMERICAN
Ticker Symbol XTNT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for XTNT stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target
$3.0
(462.64% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System

New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine Procedures BELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT)...

6 weeks ago - Accesswire

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September 18, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medic...

6 weeks ago - Accesswire

Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q2 2024 Earnings Conference Call August 9, 2024 9:00 AM ET Company Participants Brett Maas - IR Sean Browne - President and CEO Scott Neils - CFO Conference C...

3 months ago - Seeking Alpha

Xtant Medical Announces Closing of $5.0 Million Private Placement

BELGRADE, MT / ACCESSWIRE / August 9, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 months ago - Accesswire

Xtant Medical Announces $5.0 Million Private Placement

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 months ago - Accesswire

Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...

3 months ago - Accesswire

Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%

BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...

3 months ago - Accesswire

Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

BELGRADE, MT / ACCESSWIRE / July 25, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, ...

3 months ago - Accesswire

Xtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q1 2024 Results Conference Call May 15, 2024 4:30 PM ET Company Participants Brett Maas - Managing Partner, Hayden IR Sean Browne - President and Chief Execut...

6 months ago - Seeking Alpha

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance

Expects Revenue for Full Year 2024 of $116 Million to $120 Million BELGRADE, MT / ACCESSWIRE / May 15, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company foc...

6 months ago - Accesswire

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, to...

6 months ago - Accesswire

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds

BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...

6 months ago - GlobeNewsWire

Xtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript

Xtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript

7 months ago - Seeking Alpha

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical tech...

7 months ago - GlobeNewsWire

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...

8 months ago - GlobeNewsWire

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...

8 months ago - GlobeNewsWire

Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference

BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...

9 months ago - GlobeNewsWire

Xtant Medical to Participate in Upcoming Investor Conferences

BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...

1 year ago - GlobeNewsWire

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...

1 year ago - GlobeNewsWire

Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical

Expands Xtant's Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technolo...

1 year ago - GlobeNewsWire

Xtant Medical Highlights Growing Product Portfolio at NASS 2023

BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...

1 year ago - GlobeNewsWire

Xtant Medical Completes Acquisition of Surgalign's Hardware and Biologics Business

BELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...

1 year ago - GlobeNewsWire

Xtant Medical Holdings, Inc. (XTNT) Q2 2023 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ET Company Participants Matt Steinberg - IR Sean Browne - CEO Scott Neils - CFO Conference Call Partic...

1 year ago - Seeking Alpha

Xtant Medical Announces Second Quarter Revenue Growth of 32%

Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology comp...

1 year ago - GlobeNewsWire

Xtant Medical Wins Auction for Surgalign's Hardware and Biologics Business

Acquisition to Enhance Xtant's Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technolog...

1 year ago - GlobeNewsWire